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REAMBLE
he granting of clinical staff privileges to physicians is a
rimary mechanism used by institutions to uphold the
uality of care. The Joint Commission on Accreditation of
ealth Care Organizations requires that the granting of
ontinuing medical staff privileges be based on assessments
f applicants against professional criteria specified in the
edical staff bylaws. Physicians themselves are thus charged
ith identifying the criteria that constitute professional
ompetence and with evaluating their peers accordingly. Yet
he process of evaluating physicians’ knowledge and com-
etence is often constrained by the evaluator’s own knowl-
dge and ability to elicit the appropriate information,
roblems compounded by the growing number of highly
pecialized procedures for which privileges are requested.
The American College of Cardiology Foundation/
merican Heart Association/American College of Physi-
ians (ACCF/AHA/ACP) Task Force on Clinical Compe-
ence was formed in 1998 to develop recommendations for
ttaining and maintaining the cognitive and technical skills
ecessary for the competent performance of a specific
ardiovascular service, procedure, or technology. These
ocuments are evidence-based, and where evidence is not
vailable, expert opinion is utilized to formulate recommen-
ations. Indications and contraindications for specific ser-
ices or procedures are not included in the scope of these rocuments. Recommendations are intended to assist those
ho must judge the competence of cardiovascular health
are providers entering practice for the first time and/or
hose who are in practice and undergo periodic review of
heir practice expertise. The assessment of competence is
omplex and multidimensional; therefore, isolated recom-
endations contained herein may not necessarily be suffi-
ient or appropriate for judging overall competence.
The ACCF/AHA/ACP Task Force makes every effort to
void any actual or potential conflicts of interest that might
rise as a result of an outside relationship or a personal
nterest of a member of the ACCF/AHA/ACP Writing
ommittee. Specifically, all members of the Committee are
sked to provide disclosure statements of all such relation-
hips that might be perceived as real or potential conflicts of
nterest relevant to the document topic. These changes are
eviewed by the Committee and updated as changes occur.
he relationship with industry information for the Writing
ommittee members is published in the appendix of this
ocument.
Mark A. Creager, MD, FACC, FAHA
Chair, ACCF/AHA/ACP Task Force on
Clinical Competence and Training
NTRODUCTION
he disciplines of cardiac imaging using computed tomog-
aphy (CT) and magnetic resonance imaging (MRI) define
nique areas worthy of competence. Existence of multi-
isciplinary practitioners in the field, the complex nature of
he imaging devices and anatomy, and the rapidly advancing
ses of these modalities require credentialing guidelines for
hysicians in, hospital as well as private, outpatient settings.
he guidelines are broad-based and applicable to cardiovas-
ular practitioners from multiple medical backgrounds. This
tatement on clinical competence is designed to assist in the
ssessment of physicians’ expertise in the ability to apply and
nterpret cardiovascular computed tomography (CCT) and
ardiovascular magnetic resonance (CMR). The minimum
ducation, training, experience, and cognitive skills neces-
ary for the evaluation and interpretation of cardiac imaging
sing these newer approaches are specified. It is important
o note that these are minimum training and experience
equirements for the assessment of expertise in these ap-
roaches in the broadest sense. The specifications are
pplicable to most practice settings and can accommodate a
umber of ways in which physicians can substantiate exper-
ise and competence in utility of either CCT or CMR.
Moreover, it is important to stress that competence levels
or CCT and CMR are distinct and require separate
raining. This document specifically applies to cardiac ap-
lications of these two modalities. The official name for the
iscipline of magnetic resonance (MR) applied to the
ardiovascular system per the Society for Cardiovascular
agnetic Resonance (SCMR) is “cardiovascular magnetic
esonance” whether it is applied to the heart alone (includ-
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July 19, 2005:383–402 ACCF/AHA Clinical Competence Statement on Cardiac CT and MRng the coronary arteries) or the heart and the peripheral
lood vessels. Because of the complexities of the peripheral
natomy as well as the different methods of interpretation
nd acquisition, peripheral imaging using either modality is
utside the scope of this document and will require separate
ttention and training.
The Writing Committee includes representatives from
he American College of Cardiology (ACC), the American
eart Association (AHA), the American Society of Echo-
ardiography (ASE), the American Society of Nuclear
ardiology (ASNC), the Society of Atherosclerosis Imag-
ng (SAI), the Society for Cardiovascular Angiography and
nterventions (SCAI), and the SCMR. Peer review in-
luded two official representatives from the ACC and AHA;
rganizational review was done by the ASE, ASNC, SCAI,
ociety of Cardiovascular Computed Tomography (SCCT),
CMR, and SAI, as well as 40 content reviewers. This
ocument was approved for publication by the governing
odies of the ACC and AHA. In addition, the governing
oards of the ASE, ASNC, SAI, SCAI, and SCCT have
eviewed and formally endorsed this document.
ationale for developing a competence statement. In
his document, the term “cardiac disease” refers to acquired
nd congenital diseases of the heart muscle, valves, pericar-
ium, coronary arteries and veins, pulmonary veins, and
iseases of the thoracic aorta. Diseases of the pulmonary
rteries (e.g., pulmonary embolism), peripheral vascular
ystem, and carotid, renal, and intracranial vessels are
utside the realm of this document. Furthermore, this
ocument addresses other clinical imaging applications of
oth CCT and CMR. For CCT, anatomic, functional
maging, coronary calcium, non-calcified plaque assessment,
nd CCT use in congenital heart disease (CHD) will be
ncluded. For CMR, its use in anatomic, functional, and
erfusion imaging, vasodilator or dobutamine stress imag-
ng, viability, plaque assessment, valvular disease, and CHD
ill be discussed.
Coronary heart disease constitutes the most common
ause of morbidity and mortality in Western society. Sci-
ntific advances have substantially increased the diagnostic
apabilities of both CCT and CMR. Most cardiovascular
nd radiology programs do not provide formal post-training
ducation in CCT and CMR, yet there is a strong need to
stablish competence guidelines for practicing physicians in
hese emerging fields. This document does not replace the
ardiovascular Medicine Core Cardiology Training (CO-
ATS) document on CMR (1), which specifically addresses
raining requirements during cardiovascular fellowship, nor
he recommendations made by the American College of
adiology (ACR) (2). This document is intended to be and
s complementary to the SCMR statement regarding train-
ng requirements during fellowship and for practicing phy-
icians (1,3) and to recommendations by the ACR (2). It
ust be understood that the SCMR guidelines, which
equire relatively more “in laboratory” training than the
uidelines listed here, include the field of vascular imaging. ihereas cardiologists, nuclear medicine specialists, and
adiologists should possess core knowledge of cardiovascular
hysiology and imaging, it is unreasonable to expect the
ajority of such physicians to be fully conversant with all
otential uses of CCT or CMR. Thus, there is a role for
pecialists who have more in-depth understanding of the
tility and diagnostic capability of CCT and CMR.
Medical specialists trained in the distinct disciplines of
ardiovascular medicine, radiology, and nuclear medicine
re all involved in the imaging of cardiovascular diseases,
lbeit from differing perspectives. These perspectives, how-
ver, also share many common features, emphasizing the
mportance of a broadly based, multi-disciplinary approach
or management. These specialist physicians also can be
ubdivided into those who have exposure or training in
CT and those who have exposure or training in CMR.
ach of these subsets of physicians concerned with the care
f the patient with cardiovascular disease must hold a
pecialized knowledge base that is applicable to one’s par-
icular imaging discipline. This document addresses the
inimal knowledge base required for expertise, the educa-
ion and training pathways available to acquire that exper-
ise, and the requirements to maintain expertise for each of
he two related disciplines that involve tomographic cardiac
maging with CCT and CMR. Accordingly, this document
s presented in two major sections: 1) CCT, and 2) CMR.
ach section describes the cognitive, clinical, and/or proce-
ural skills required for expertise, the training necessary for
chieving competence, and the means for maintaining that
xpertise and competence.
OMPUTED TOMOGRAPHY (CT)
verview of X-Ray CT
Computed tomography” is a generic term that can apply to
everal methods currently employed in the evaluation of
ardiovascular diseases. The first discussion must be one of
emantics in defining CT derived in a specific manner using
-ray information from multiple sites. From here forward,
T will refer to the latter method partly by tradition and
ostly by convention.
The development of CT, resulting in widespread clinical
se of CT scanning by the early 1980s, was a major
reakthrough in clinical diagnosis. Imaging a thin axial
ross-section of the body avoided superposition of three-
imensional (3D) structures onto a planar two-dimensional
2D) representation, as is the problem with conventional
rojection X-ray. The basic principle of CT is that a
an-shaped, thin X-ray beam passes through the body at
any angles to allow for cross-sectional images. The cor-
esponding X-ray transmission measurements are collected
y a detector array. Information entering the detector array
nd X-ray beam itself is collimated to produce thin sections
nd avoid unnecessary photon scatter. The transmission
easurements recorded by the detector array are digitizednto picture elements (pixels) with known dimensions. The
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econstructed according to the attenuation of the X-ray
eam along its path using a standardized technique termed
filtered back projection.” Gray-scale values for pixels within
he reconstructed tomogram are defined with reference to
he value for water and are called “Hounsfield Units” (HU)
for the 1979 Nobel Prize winner, Sir Godfrey N.
ounsfield) or simply “CT numbers.” Air attenuates the
-ray less than water, and bone attenuates it more than
ater, so that in a given patient, the HU may range from
1,000 HU (air) through 0 HU (water) to approximately
1,000 HU (bone cortex). A range of 2,000 gray-scale
alues represents densities of various hard and soft tissues
ithin the body and between these two extreme limits.
The CT technology has significantly improved since its
ntroduction into clinical practice in 1973. Current conven-
ional scanners used for cardiac and cardiovascular imaging
ow employ either a rotating X-ray source with a circular,
tationary detector array (spiral or helical CT) or a rotating
lectron beam (electron beam computed tomography
EBCT]). Continuous or step increments of the patient
able using electron beam methods allow imaging at 50 to
00 ms or continuous scanning (spiral or helical CT or
ulti-detector computed tomography [MDCT]), allowing
or image reconstruction windows now on the order of 200
o 400 ms with short inter-scan delay. Today, 64-slice
DCT scanners provide enhanced scan modes of temporal
esolution as low as 165 ms, and in multi-sector mode a
ange of temporal resolution as low as 100 ms. Improved
emporal resolution should lead to lower motion artifacts
nd possibly higher diagnostic rates. Reconstruction algo-
ithms and multi-row detectors common to both current
BCT and spiral/helical CT have been implemented,
nabling volumetric imaging, and multiple high-quality
econstructions of various volumes of interest can be done
ither prospectively or retrospectively, depending on the
ethod.
Although the purpose of this statement is to provide an
verview of the requirements of competence in current
CT and MRI technology, continued efforts will be re-
uired to maintain competence as additional technological
mprovements and modifications are made in CCT hard-
are and software.
inimal knowledge and skills required for expertise in
CT. Table 1 lists common CCT procedures performed
urrently in many hospital-based inpatient and outpatient
maging centers and in some private imaging clinics.
Cognitive skills required to demonstrate competence in
CT are summarized in Table 2. Candidates for compe-
ence in CCT shall have completed a formal residency in
eneral radiology or nuclear medicine or will have com-
leted an Accreditation Council for Graduate Medical
ducation (ACGME)-approved cardiovascular fellowship.
thorough knowledge and understanding of cardiac and
ascular anatomy is required. Because cardiology, nuclear
edicine, and radiology training is very much involved withnatomic definition, this requirement should be met or
ould have been met by individuals completing an
CGME-approved cardiovascular fellowship, nuclear med-
cine residency, or general radiology residency. Likewise,
haracteristics of the heart in health and disease by tradi-
ional cardiac imaging methods (echocardiography, nuclear
edicine, and angiography) will provide a significant back-
round for application to CCT. These dynamic tomo-
raphic or projection imaging techniques of the heart are
ommonplace in formal cardiology training, so little addi-
ional instruction is required when interpreting dynamic
CT sequences of the heart for cardiologists (e.g., evaluat-
able 1. Classification of CCT Procedures
ardiac:
● Static tomographic and 3D non-contrast and contrast-enhanced
anatomy of the heart, heart chambers, and pericardium (electron
beam tomography [EBT] and multi-detector computed tomography
[MDCT])
● Dynamic contrast-enhanced assessment of left and right ventricular
function (EBT and MDCT)
● Quantitative coronary artery calcium scoring and interpretation
(EBT and MDCT)
● Performance and interpretation of tomographic and 3D contrast-
enhanced CCT coronary angiography, including native and
anomalous coronary vessels and coronary bypass grafts, aortic root,
proximal pulmonary arteries, superior and inferior vena cavae,
pulmonary veins (EBT and MDCT), and common congenital
abnormalities involving the heart and central vasculature
horacic Aorta:
● Static tomographic and 3D non-contrast and contrast-enhanced
anatomy of central vasculature (thoracic aorta) (EBT and MDCT)
● Performance and interpretation of tomographic and 3D contrast-
enhanced CCT central vascular angiography including aortic arch
and thoracic aorta (EBT and MDCT)
able 2. Cognitive Skills Required for Competence in CCT
eneral:
● Knowledge of the physics of CT and radiation generation and
exposure
● Knowledge of scanning principles and scanning modes for non-
contrast and contrast-enhanced cardiac imaging using multi-
detector and/or electron beam methods
● Knowledge of the principles of intravenous iodinated contrast
administration for safe and optimal cardiac imaging
● Knowledge of recognition and treatment of adverse reactions to
iodinated contrast
● Knowledge of the principles of image postprocessing and
appropriate applications
ardiac:
● Clinical knowledge of coronary heart disease and other
cardiovascular diseases
● Knowledge of normal cardiac, coronary artery, and coronary venous
anatomy, including associated pulmonary arterial and venous
structures
● Knowledge of pathologic changes in cardiac and coronary artery
anatomy due to acquired and congenital heart disease
● Basic knowledge in ECG to recognize artifacts and arrhythmias
orta:
● Knowledge of normal thoracic arterial anatomy
● Knowledge of pathologic changes in central arterial anatomy due toacquired and congenital vascular disease
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July 19, 2005:383–402 ACCF/AHA Clinical Competence Statement on Cardiac CT and MRng ventricular function by watching the wall motion
hroughout a cardiac cycle). Cardiac physiology is also vital
or CCT and CMR, and basic training should be part of
oth formal cardiology fellowship and radiology residency.
ompetence in peripheral CT is beyond the scope of this
eport. A brief overview of the technical aspects of CCT is
ncluded to facilitate understanding of the terms used in the
ubsequent sections of this report and is not intended to be
omprehensive.
Coronary artery calcium quantification is now common-
lace as a means of detecting coronary and peripheral
ascular atherosclerotic disease, but will require specific
CT training in addition to traditional radiology residency,
uclear medicine residency, or cardiology fellowship train-
ng. A full discussion of computer workstation methods is
eyond the scope of this document, but the candidate will
e required to show competence in manipulation of the
omographic datasets.
Myocardial perfusion imaging can be performed using
lectron beam tomography (EBT) (4) and follows principles
f first-pass kinetics and perfusion imaging by nuclear
edicine methods; however, this application is not yet
ppropriately validated for routine use in cardiac CT.
ecause CCT is expected to undergo rapid technical evo-
ution, current training requirements specifically cover non-
ontrast studies and contrast studies involving angiography
nd function, but not perfusion imaging. As this modality
volves and further matures, training requirements may
hange.
As many CCT studies are done before and after intrave-
ous administration of iodinated contrast, a thorough un-
erstanding of contrast injection methods, adverse events
nd their treatments, and contrast kinetics in patients will be
equired. In particular, knowledge is needed in the methods
f contrast-enhanced imaging of the pericardium, right
entricle (RV), right atrium, and superior and inferior vena
avae as well as imaging of the left heart, surrounding great
essels, and the central circulation.
T physics and nature of radiation exposure. The phy-
ician will be required to demonstrate competence in the
rinciples of CCT imaging using EBT and/or MDCT and
omographic imaging production. Candidates should re-
eive didactic lectures from a qualified CT-trained physician
nd/or physicist on the basic physics of CT in general and
f CCT in particular.
BT. Electron beam tomography is a Food and Drug
dministration (FDA)-approved body-imaging device de-
eloped over 20 years ago and is the only CT device
pecifically designed from inception for cardiac imaging.
ince EBT first appeared in 1984, there has been significant
alidation for this approach for cardiac and body imaging,
ith imaging times as low as 50 ms. The EBT method is
istinguished by its use of a scanning electron beam rather
han a traditional X-ray tube and mechanical rotating device
sed in current “spiral” single and multiple detector scan- ters. The electron beam (cathode) is steered by an electro-
agnetic deflection system that sweeps the beam across the
istant anode, a series of fixed “target” rings. A stationary
ingle or multi-level detector lies in apposition to the target
ings. The technique can be used to quantify ventricular
natomy and global and regional function (5), for quanti-
ation of coronary artery calcified plaque (6–8), non-
nvasive coronary angiography (9–12), and central and
eripheral vascular anatomy and angiography. There have
een three iterations for EBT since it was introduced
linically in the early 1980s. In addition to the standard
0-ms and 100-ms scan modes common to all EBT
canners, current generation units are capable of imaging
peeds as fast as 33 ms per tomographic section, as well as
ulti-level image acquisition in the high resolution mode.
DCT. Helical/spiral CT has undergone considerable
hanges in the past five years, from a single slice/detector to
ultiple slices/detectors. This modality employs a rotating
-ray source with a circular, stationary detector array.
ontinuous incrimination of the patient table has enabled
ontinuous scanning (spiral or helical CT), allowing for
mage reconstruction windows on the order of 165 to 400
s with shortened inter-scan delay. Reconstruction algo-
ithms and multi-row detectors have been implemented,
nabling volumetric imaging, and multiple high-quality
econstructions of various volumes of cardiovascular interest
an be done in retrospect with even shorter image recon-
truction windows (multi-sector reconstructions). Current
eneration MDCT systems are capable of acquiring data
rom 40 or 64 (and potentially greater) levels of the body
imultaneously. Cardiac imaging is facilitated using electro-
ardiographic (ECG) gating in either a prospective or
etrospective mode (11–13). The MDCTs differ from
ingle-slice helical or spiral CT systems principally by the
esign of the detector arrays and data acquisition systems.
he new design allows the detector arrays to be configured
lectronically to acquire multiple levels of various slice
hickness simultaneously. Measurement of the true maxi-
um (end-diastolic) and true minimum (end-systolic) vol-
mes are more problematic with MDCT (as compared to
BT and especially CMR) owing to lower temporal
esolution.
In MDCT systems, like the preceding generation of
ingle-slice helical scanners, the X-ray photons are gener-
ted within a specialized X-ray tube mounted on a rotating
antry. The patient is centered within the bore of the gantry
uch that the array of detectors is positioned to record
ncident photons after traversing the patient. Within the
-ray tube a tungsten filament allows the tube current to be
ncreased (in mA) which proportionately increases the
umber of X-ray photons for producing an image. This
bility to vary the power is a substantial design difference
ith current generation EBT systems, which has only two
A settings (14). The attenuation data (after passing fromhe source, through the body, and incident on the detector
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ACCF/AHA Clinical Competence Statement on Cardiac CT and MR July 19, 2005:383–402rray) are recorded and transformed through a filtered
ack-projection into the CT image. This final step is
ommon to both EBT and MDCT.
adiation dose. The CCT utilizes X-rays, a form of
onizing radiation, to produce the information required for
enerating CCT images. Although ionizing radiation from
atural sources is part of our daily existence, a role of health
are professionals involved in medical imaging is to under-
tand the potential risks of the test and balance those against
he potential benefits. This is particularly true for diagnostic
ests which are applied to healthy individuals as part of a
isease-screening or risk-stratification program. Health care
rofessionals must have an understanding of the exposure
nvolved in CCT to effectively advise candidates for
maging.
Because of the dangers of ionizing radiation, a compre-
ensive understanding must be obtained in physics and
adiation safety for anyone involved with CCT. Patient
oses for CCT acquisition should be set at the lowest values
hat are consistent with satisfactory image quality. Most
andidates will likely have had some didactic training
egarding radiation physics during radiology residency, nu-
lear medicine residency, or cardiology fellowship. How-
ver, specific instructions in the need to keep radiation
xposure to the patient to a minimum when performing
CT will be required.
In general, there are differences in radiation exposure
epending on the examination performed and the CT
ethod (EBT vs. MDCT). Adoption of the effective dose as
standard measure of dose allows comparability across the
pectrum of medical and non-medical exposures. “The
ffective dose is, by definition, an estimate of the uniform,
hole-body equivalent dose that would produce the same
evel of risk for adverse effects that results from the non-
niform partial body irradiation. The unit for the effective
ose is the milliSievert (mSv)” (www.fda.gov/cdrh/ct/
qu.html). The typical radiation dose for calcium scanning
sing EBT is 0.5 to 0.7 mSv, increasing with 4- to 16-slice
DCT (prospective gating) to 0.8 to 1.5 mSv, and for
DCT (retrospective gating) is up to 6.2 mSv (13–17).
adiation dose exposure for coronary angiography is much
igher. Using EBT coronary angiography yielded effective
oses of 1.5 and 2.0 mSv for male and female patients,
espectively (15). Effective doses delivered during 16-slice
DCT coronary angiography are reported to be 6.7 to 10.9
Sv for male patients and 8.1 to 13.0 mSv for female
atients (15,16).
In MDCT coronary angiography, the dose can be re-
uced by 30% to 50% using ECG-controlled dose modu-
ation techniques (18). For both EBT and MDCT, the
adiation dose increases with thinner slices and more over-
apping images (13). In comparison, routine conventional
iagnostic X-ray coronary angiography is associated with
ffective doses of 2.1 and 2.5 mSv for male and female
atients, respectively (15). Depending on the operator and
he nature of the diagnostic procedure, the effective dose of c-ray coronary angiography can be significantly higher.
nderstanding the appropriate use of prospective triggering
EBT), prospective gating (MDCT), and retrospective gat-
ng (MDCT), especially given the patient radiation dose
mplications is important (9,13–16).
The current EBT configuration has two power (mA)
ettings and performs prospective triggering through only
10° of arc, so radiation dose is reduced, and there is limited
pportunity either to increase or decrease radiation dose to
he patient with varying protocols. However, this is not the
ase with MDCT angiography, which images through 360°
f radiation exposure.
There are various choices with MDCT that can dramat-
cally change the patient radiation dose during coronary
omputed tomography angiography (CTA). Because of
apid technical advances, scanning protocols for MDCT
ave not yet been standardized. Controversies about opti-
al tube current and voltage are ongoing. Dose (in mA) can
e increased or decreased, and this is most often based upon
he body habitus of the patient (16). Furthermore, slice
hickness can be decreased. However, one 16-slice MDCT
tudy that utilized high mA and 0.5-mm slice thickness for
TA (thus achieving nearly isotropic imaging) reported
adiation doses as high as 24.2 mSv per patient (13). This
an be reduced by using dose modulation (turning down the
adiation exposure during parts of the cardiac cycle that
maging is not useful) during systolic cardiac phases; how-
ver, this is also dependent upon the patient’s heart rate
17), and cannot be applied in all cases. Although the
fficacy of dose modulation depends on the heart rate, it can
heorectically be applied to any heart rate with the 64-
etector CT scanner. Beta-blockade to achieve heart rates
elow 60 beats/min is still most often part of the MDCT
ngiogram (10,11,18,19).
T laboratory requirements. Defining the specific re-
uirements for a valid CCT laboratory is beyond the scope
f this physician competence document. However, some
eneral aspects of the appropriate CT environment can be
onsidered. A continuous quality control (QC) program
ust be established for all CT units with the assistance of a
ualified medical physicist and a Level 3-trained physician
training levels are described in the following text). The
canners must be staffed by qualified CT technologists with
ppropriate background and/or training in CCT imaging.
Several states require all CT operators to qualify for a
tate permit. A current permit should be held by all
echnologists and Level 2- and 3-trained physicians, when
equired by state law.
raining to achieve clinical competence in CCT (Table 3).
he recommendations for all levels of training in the
ollowing text represent a cumulative experience, and it is
xpected that for many practicing clinicians the training will
ot be continuous. A summary of the training requirements
s given in Table 3. Time spent at didactic continuing
edical education courses specifically targeting CCT canontribute to the total time. Due to the advancement in the
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raining medias, the committee felt that some training can
ow be obtained outside the laboratory setting. However,
or all Level 2 and 3 requirements, minimum time in a CCT
aboratory is half of the time listed, with the other half
arnered by supervised time, CT exposure and other
ourses, case studies, CD/DVD training, time at major
edical meetings devoted to performance of CCT, or other
elevant educational training activities, as a few examples.
everal aspects of CCT can be learned from the general CT
xpert, including use of the workstation, tomographic im-
ging, and radiation physics, among others. The caseload
ecommendations may include studies from an established
eaching file, previous CCT cases, and electronic/on-line
xperience or courses.
For all levels of competence, it is expected that the
andidate will attend lectures on the basic concepts of CCT
nd include parallel self-study reading material. A basic
nderstanding of CCT should be achieved, including the
hysics of CCT imaging, the basics of CCT scan perfor-
ance, safety issues in CCT performance, post-processing
ethods, and the basics of CCT interpretation as compared
ith other cardiovascular imaging modalities, which include
chocardiography, nuclear medicine, CMR, and invasive
ardiac and peripheral X-ray angiography.
EVEL 1 TRAINING. Level 1 is defined as the minimal
ntroductory training for familiarity with CCT, but is not
ufficient for independent interpretation of CCT images.
he individual should have intensive exposure to the meth-
ds and the multiple applications of CCT for a period of at
east four weeks. This should provide a basic background in
CT for the practice of adult cardiology or for general
adiology. During this cumulative four-week experience,
ndividuals should have been actively involved in CCT
nterpretation under the direction of a qualified (Level 2- or
evel 3-trained) physician-mentor. There should be a
entored interpretative experience of at least 50 cases for all
tudies in which other cardiovascular imaging methods are
lso available; correlation with CCT findings and interpre-
ation is strongly encouraged and should be included if
ossible. As much as possible, studies should consist of
rocedures outlined in Table 1. Independent performance
f CCT is not required for Level 1, and the mentored
able 3. Requirements for CCT Study Performance and Interpre
Cumulative Duration of Training
evel 1 4 weeks*
evel 2—non-contrast 4 weeks*
evel 2—contrast 8 weeks*
evel 3 6 months*
This represents cumulative time spent interpreting, performing, and learning about
epresent supervised laboratory experience. In-lab training time is defined as a minimu
eaching file, previous CCT cases, journals and/or textbooks, or electronic/on-line conterpretive experience may include studies from an estab- aished teaching file or previous CCT cases and also the
otential for CD/DVD and on-line training.
EVEL 2 TRAINING. Level 2 is defined as the minimum
ecommended training for a physician to independently
erform and interpret CCT. This is an extension of Level 1
raining and is intended for individuals who wish to practice
r be actively involved with CCT performance and
nterpretation.
OMPETENCE IN NON-CONTRAST CCT. For those physi-
ians only interested in the ability to interpret non-contrast
T studies (the “heart scan”), there are separate require-
ents for non-contrast Level 2 training (Table 4). The
uccessful candidate will demonstrate competence in anal-
sis and interpretation of cardiac and proximal aorta calci-
cation data. The acquisition, post-processing, and inter-
retative learning curve for this procedure is rapid, but
ompetence must be defined. A specific requirement for the
hysician only credentialed to interpret non-contrast CCT
tudies will be training for a minimum of four weeks
including coursework, scientific meetings and continuing
edial education [CME]/on-line training) with 150 cases
nterpreted, with a minimum of 50, which should be
nterpreted with a mentor.
OMPETENCE IN CONTRAST CCT. Physicians seeking Level
training inclusive of contrast and non-contrast studies will
eed to interpret 50 non-contrast cases with more time and
ases specifically targeting contrast. Training in contrast and
on-contrast CT may occur concomitantly.
The minimum requirement for the dual credentialing is
ight weeks of cumulative experience in a program actively
erforming CCT examinations in a clinical environment.
n-lab training time is defined as a minimum of 35 h/week.
wenty hours of didactic CME courses specifically target-
ng CCT can contribute to the total time. The variety of
xposure should include as much as possible the list of
tudies outlined in Table 1.
During this training experience, each candidate should
ctively participate in CCT study interpretation under the
irection of a qualified (preferably Level 3-trained)
hysician-mentor. Some supervision can be by an expert
on-cardiac CT physician for some of the basics of CT/
eformatting, workstation, radiation physics, and so forth.
he candidate should be involved with the interpretation of
n to Achieve Level 1, 2, and 3 Clinical Competence
imum Number of Mentored
Examinations Performed
Minimum Number of Mentored
Examinations Interpreted
— 50†
50 150†
50 150†
100 300†
, and need not be a consecutive block of time, but at least 50% of the time should
5 h/week. †The case load recommendations may include studies from an established
CME.tatio
Min
CCTt least 150 CCT examinations (with contrast enhance-
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nvolved in the acquisition and interpretation of the case in
t least 50 studies. Cases should reflect the broad range of
nticipated pathology. Didactic studies should include ad-
anced lectures, reading materials, and formal case presen-
ations. These didactic studies should include information
n the sensitivity, specificity, accuracy, utility, costs, advan-
ages, and disadvantages of CCT as compared with other
ardiovascular imaging modalities. Each physician should
eceive documented training from a CCT mentor and/or
hysicist on the basic physics of CT in general and on CCT
n particular. Lectures will include discussions of anatomy,
ontrast administration and kinetics, and the principles of
D imaging and post-processing. The physician should also
eceive training in principles of radiation protection, the
azards of radiation exposure to both patients and CT
ersonnel, and appropriate post-procedure patient monitor-
ng. Finally, the physician should be thoroughly acquainted
ith the many morphologic and pathophysiologic manifes-
ations and artifacts demonstrated on CCT images.
A physician with Level 2 training should demonstrate
lear understanding of the various types of CT scanners
vailable for cardiovascular imaging (EBT and MDCT) and
nderstand at a minimum the common issues related to
maging, post-processing, and scan interpretation, including:
Important patient historical factors (indications and risk
factors that might increase the likelihood of adverse
reactions to contrast media, if applicable)
Radiation exposure factors
CT scan collimation (slice thickness)
able 4. Requirements for Level 2 and Level 3 Clinical Compete
Level 2
nitial Experience ● NON-CONTRAST
REQUIREMENTS
● Board certification or eligibility, valid
medical license, and completion of 4
weeks of training (to include
coursework, scientific meetings, and
courses/on-line training)
● AND 150 non-contrast CCT
examinations (for at least 50 of these
cases, the candidate must be physically
present, and be involved in
interpretation of the case)
● AND completion of 20 h of courses/
lectures related to CT in general and/or
CCT in particular
ontinuing Experience 50 non-contrast CCT exams conducted
and interpreted per year
ontinuing Education 20 h Category I every 36 mCT scan temporal resolution (scan time per slice) lTable speed (pitch)
Field of view
Window and level view settings
Algorithms used for reconstruction
Contrast media
Post-processing techniques and image manipulation on
work stations
Total radiation dose to the patient
EVEL 3 TRAINING. Level 3 training represents the high-
st level of exposure/expertise that would enable an
ndividual to serve as a director of an academic CCT
ection or director of an independent CCT facility or
linic. This individual would be directly responsible
or QC and training of technologists and be a mentor
o other physicians seeking such training. The mini-
um cumulative training period will be six months, to
nclude all of the didactic requirements of Level 2
raining as well as participation in CCT study inter-
retation under the direction of a qualified (Level
-trained) physician-mentor. In-lab training time is
efined as a minimum of 35 h/week. Level 3 candi-
ates should be involved with interpretation of at least
00 non-contrast and 300 contrast CCT examina-
ions. For at least 100 of these cases, the candidate
ust be physically present and be involved in the
cquisition and interpretation of the case. Cases
hould reflect a broad range of pathology.
In addition to the recommendations for Level 1
nd Level 2 training, Level 3 training should include
ctive and ongoing participation in a basic research
in CCT
Level 3
LL CCT
QUIREMENTS
ard certification or
ibility, valid medical license,
completion of 8 weeks
mulative) of training in
T
D 150 contrast CCT
minations. For at least 50 of
se cases, the candidate must
physically present, and be
olved in the acquisition and
erpretation of the case
D evaluation of 50 non-
trast studies
D completion of 20
ectures related to CT in
eral and/or CCT in
ticular
● Board certification or eligibility, valid
medical license, and completion of 6
months (cumulative) of training in
CCT,
● AND 300 contrast CCT
examinations. For at least 100 of
these cases, the candidate must be
physically present, and be involved in
the acquisition and interpretation of
the case
● AND evaluation of 100 non-contrast
studies
● AND completion of 40 h of courses/
lectures related to CT in general
and/or CCT in particular
ntrast CCT exams
nducted and interpreted
r year
100 contrast CCT exams conducted
and interpreted per year
s of CCT 40 h Category I every 36 months
of CCTnce
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linical and educational experiences. Additionally, Level
CCT physicians should have appropriate knowledge
f alternative imaging methods, including the use and
ndications for specialized procedures including echo-
ardiography and vascular ultrasound, CMR, and nu-
lear medicine/positron emission tomography (PET)
tudies. A summary of the training requirements is given
n Table 3.
ompetence Considerations Unique to Specific Applications
on-contrast cardiac CT including coronary artery cal-
ium. Quantification of coronary artery (as well as central
nd peripheral artery) calcification has been established as a
eans to estimate atherosclerotic plaque burden. Calcifica-
ion scores have been shown to provide individualized
ardiovascular risk assessment independent of and incre-
ental to conventional cardiovascular risk factors (6–8).
It is to be emphasized, however, that a study done
rimarily to quantify coronary artery calcification (EBT or
DCT) will require not only separating native coronary
alcification from aortic and mitral valvular and pericardial
alcification, but also defining the potential for gross cardiac
hamber abnormalities as well as potential abnormalities of
he pericardium. Proximate calcification and/or enlarge-
ent of the ascending aorta and the descending thoracic
orta, included in the heart in the imaging field, should also
e recognized if imaged. Tables 3 and 4 discuss the
ecommended number of cases for proficiency for non-
ontrast studies (not included in the totals for contrast CT).
Physicians must demonstrate competence in analysis and
nterpretation of cardiac and proximate aorta calcification
ata. The learning curve for this procedure is rapid, but
ompetence must be defined. For those physicians inter-
sted in full Level 2 competence (to include contrast
tudies), this non-contrast requirement can be done con-
omitantly with training for contrast studies. Specific re-
uirements are outlined in Table 4.
on-invasive coronary CT angiography (CTA). Perfor-
ance and interpretation of CTA involving the intravenous
dministration of 60 to 140 ml of iodinated contrast during
prolonged breath-hold is significantly more challenging
han coronary calcium assessment. Understanding the anat-
my, which is learned most directly from conventional
oronary arteriography, is vital to the applicant, and it is
xpected that all the candidates will have adequate under-
tanding of the coronary distribution and anatomy. The
ortuosity of the vessels and limited temporal resolution
MDCT) or spatial resolution (EBT) contributes to this
ifficulty. However, studies have demonstrated a high sen-
itivity and specificity in the major epicardial segments for
he diagnosis of significant (greater than 50% diameter)
bstructive coronary artery disease (CAD) as compared to
onventional X-ray coronary angiography using EBT and
6-slice MDCT scanners (9–12,18,19). The successful
andidate will demonstrate competence in analysis and mnterpretation of cardiovascular angiographic data. The
ost-processing and interpretive learning curve is not rapid,
nd much of the overall time spent training in CCT should
hus be directed at non-invasive angiography training. This
s necessary for clinicians to obtain both clinical expertise
nd to become technically competent in 2D and 3D
endering using a computer workstation. For clinicians to
btain expertise in performance of CTA, a majority of the
ases must be directed at the performance of these contrast
tudies. Cases should reflect the broad range of coronary
rtery and bypass graft pathology.
HD evaluation by CCT. Use of CCT is an important
esource for the evaluation of known or suspected CHD in
hildren and adults. Echocardiography and CMR are the
ost commonly used technologies for assessment of CHD.
ardiovascular computed tomography can provide accurate
D assessment of the heart, offering additional clarity when
ndings are in question. The ability to assess CHD quickly
llows for studies either without any sedation in most cases,
r with markedly reduced sedation requirements, which is
articularly useful in children. However, CCT requires
xposure to ionizing radiation and iodinated contrast. The
CT technique has excellent spatial resolution, and can be
tilized to assess the great vessels, including anomalies of
he aorta, pulmonary artery, patent ductus arteriosus, pul-
onic or tricuspid valve atresia, persistent left superior vena
ava, anomalous pulmonary veins, assessment of intra-
ardiac shunts, and the presence of bronchial collaterals.
A properly trained CCT practitioner at Level 2 should be
ble to determine the appropriate indications for echocar-
iography, CCT, or CMR in CHD assessment. This is
specially true in the assessment of pediatric CHD patients,
here the information gained from the CCT examination
oes not require the risks associated with the general
nesthesia or conscious sedation required to perform CMR,
ut does expose the young patient to ionizing radiation
where radiation exposure may be more clinically important
han in adults) and iodinated contrast.
A cardiologist, nuclear medicine specialist, or radiologist
ith Level 2 or Level 3 CCT competence should be capable
f recognizing simple CHD. However, as with echocardi-
graphy, few adult cardiology or radiology training pro-
rams have a sufficient case load and case mix of complex
HD lesions to ensure an adequate level of training.
lthough those trained in CCT may be able to recognize
he presence of a complex congenital lesion, most CCT
rograms will be unable to provide enough experience to
rainees to develop the special skills necessary to evaluate
omplex CHD, post-surgical appearance, and post-surgical
omplications. Practitioners who wish to perform CCT for
dult and pediatric CHD patients need special experience.
recommended case load (as part of the total number
ecommended for competence) for Level 2 is 25 cases; for
evel 3 it is 50 cases, with an additional 20 cases annually to
aintain competence.
C
b
o
f
L
e
s
C
i
s
f
(
a
s
i
e
m
m
n
p
s
N
e
t
e
D
s
s
m
C
f
c
r
b
f
S
o
P
t
i
i
i
C
t
s
C
g
h
w
n
t
r
w
t
m
m
f
d
o
r
r
t
t
b
a
s
h
f
C
a
P
a
o
L
d
s
T
T
T
M
392 Budoff et al. JACC Vol. 46, No. 2, 2005
ACCF/AHA Clinical Competence Statement on Cardiac CT and MR July 19, 2005:383–402ardiac function and structure assessment by CCT. Electron
eam tomography was initially validated for quantification
f LV and RV global and regional systolic and diastolic
unction—demonstrating similarities to other methods.
ower temporal resolution MDCT data results in lower
jection fraction (EF) estimates than reference methods
uch as CMR. A thorough knowledge of the utilization of
CT reconstructions of short axis, long axis, and trans-axial
maging is necessary. These imaging planes have been
tandardized for multiple imaging methods (20).
The use of CCT has been demonstrated to be accurate
or the measurement of RV and LV mass, volumes, and EF
5,21), and has been used to quantify calcified plaque on the
ortic and mitral valve (22). However, it is inferior to
pecially sequenced CMR and echocardiography for assess-
ng valvular function and volumes. For clinicians to obtain
xpertise in performance of CCT functional assessment, a
inimum number of cases must be directed at the perfor-
ance of these contrast studies. As part of the total cases
ecessary for Level 2 competence, at least 25 cases should be
erformed and 50 cases interpreted with mentorship. Cases
hould include assessment of the thoracic aorta.
uclear/CT hybrid devices. Hybrid devices are rapidly
volving to incorporate state-of-the-art, high-speed MDCT
echnology, along with the latest PET and single-photon
mission computed tomography (SPECT) detector systems.
ual-modality imaging presents an opportunity to use a
ingle piece of equipment for distinctly different purposes,
uch as the determination of perfusion, function, and
etabolism (PET-SPECT) or coronary calcification and
TA. Therefore, a laboratory may use these hybrid devices
or multiple purposes, thereby reducing space requirements
ompared to installation of two separate systems, and also
educing overall financial cost involved in the purchase of
oth CT and PET-SPECT cameras. There is the potential
or a hybrid system to provide attenuation correction for
PECT, thereby further improving the diagnostic accuracy
f more traditional radionuclide techniques.
Furthermore, the combination of SPECT-CT or
ET-CT may provide an evaluation of coronary anatomy in
able 5. Documentation and Maintenance of Clinical Competen
Documentation of
Competence Training Guide
raining completed after
July 1, 2008
Level 2 or Level 3 training as outlined
raining completed before
July 1, 2008
Level 2 training OR interpretation of at
where the candidate is physically prese
and interpretation of the case) and atte
20 h of devoted CCT classes
Level 3 training OR interpretation of at l
where the candidate is physically prese
and interpretation of the case) and atten
devoted to CCT
aintenance of competence Contrast CCT examinations per year be
Level 2: 50 Level 3: 100he same setting as perfusion imaging. The functional
maging (PET or SPECT) combined with anatomic imag-
ng (CT calcium or CTA) may also offer superior prognostic
nformation, although this has not yet been demonstrated.
urrent hybrid systems available do not include state-of-
he-art MDCT systems. As the CT hardware in hybrid
ystems becomes more robust, the feasibility of combining
TA, coronary calcium scoring, and SPECT- or PET-
ated perfusion imaging will become a reality. Given that
ybrid devices or sequential scintigraphic and CCT imaging
ill result in increased radiation exposure, expertise is
eeded to know in whom to apply these complementary
echniques (23).
To facilitate the availability of new technology in all
egions of the country, eventually including rural areas
here there is frequently limited access to individuals
rained in the latest technologies, consideration should be
ade to allow “cross-over” training for CT and nuclear
edicine technologists. Similarly, “cross-over” may occur
or physicians, including cardiology fellows, radiology resi-
ents, and nuclear medicine residents as well as for cardi-
logists, nuclear medicine physicians, and radiologists cur-
ently in practice. Each of these specialties incorporates
adiation safety into their training programs. However,
hose trained in nuclear cardiology will require additional
raining in CCT detector physics and instrumentation,
ecause individuals trained primarily in CCT will require
dditional time to learn physics and instrumentation of
cintillation techniques and to review aspects of radionuclide
andling and safety. Otherwise, requirements for the per-
ormance and interpretation of radionuclide, PET, and
CT studies should follow previously established guidelines
nd the recommendations set forth in this document.
ROOF OF TRAINING. Documentation of training can be
chieved by means of letters or certificates from the director
f a fellowship training program or from individuals who are
evel 2 or Level 3 qualified in hospital-based or indepen-
ent imaging centers or clinics. This documentation should
tate the dates of training and that the candidate has
CCT
Proof of Competence
Letter of certification from training supervisor
OR letter attesting to competence from
Level 2- or 3-trained physician150 studies (in which 50
volved in the acquisition
ce in at least
00 studies (in which 100
volved in the acquisition
in at least 40 h of classes
med and interpreted:ce in
lines
least
nt, in
ndan
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lements (Levels 1, 2, and 3) (Table 5).
Practicing physicians can achieve appropriate training in
CT without enrolling in a formal CCT training program.
owever, the same prerequisite medical knowledge, medi-
al training, and goals as outlined in the previous text are
equired. Directly working with a mentor on an ad-hoc basis
s acceptable, but formalized time of cumulative exposure
or Levels 1 to 3 competence will be maintained. Currently,
practicing physician seeking this training should have
ompleted an ACGME-approved cardiovascular diseases
ellowship, a general radiology residency, or a nuclear
edicine residency.
aintaining expertise in CCT. All individuals are re-
uired to provide evidence of continuing expertise in CCT.
ndividuals who are currently at Level 1 or Level 2 training
an advance to Level 2 or Level 3 by pursuing independent
dvanced studies from either an academic center or an
ndependent center specializing in CCT. No formal mech-
nisms currently exist regarding assurance of continuing
ompetence. The field of CCT has expanded rapidly, and
ngoing procedural and technical improvements are
xpected.
Maintenance of CCT expertise requires both ongoing
ontinuing education and regular performance and interpre-
ation of clinical and research CCT examinations. Physi-
ians should periodically attend postgraduate courses and
orkshops that focus on clinical applications of CCT,
specially those that emphasize new and evolving techniques
nd developments. In addition, physicians should seek to
ompare the quality, completeness, and results of their own
xaminations with those presented at scientific meetings
nd in professional publications. Level 2- and 3-trained
ndividuals will be required to document and continue
ategory I CME in the area. The recommendations for
aintaining Level 2 training is a minimum of 20 h of
oursework devoted to CCT over a 3-year period of time.
he recommendations for maintaining Level 3 training is a
inimum of 40 h of coursework devoted to CCT over a
-year period.
In conjunction with guidelines provided for other cardio-
ascular imaging modalities, it is recommended that at least
0 CCT examinations annually be performed and inter-
reted for those at Level 2 and 100 CCT examinations for
hose at Level 3 (Table 5).
rior experience to qualify for Levels 2 and 3 clinical
ompetence for CCT. It is expected that a substantial
umber of practitioners from multiple specialties have been
erforming these studies for some time before the creation
f these guidelines. Thus, these practitioners can qualify for
ompletion of Level 2 or Level 3 training by having
chieved the minimum criteria set forth below by July 1,
008, as well as board certification and completion of an
CGME-approved radiology or nuclear medicine residency
r cardiology fellowship, or at least two months of formal
raining in CCT. Proof of competence can be obtained by a retter of attestation by a Level 3-trained physician who has
verread studies, or by letters or certificates from the
raining supervisor (Table 5).
Level 2 training: substantive activities in CCT over the
ast 3 years, with documented involvement in the perfor-
ance and interpretation of at least 150 studies (at least half
ith contrast enhancement), and at least 20 h of coursework
evoted to CCT.
Level 3 training: activities in CCT to include directing a
CT laboratory with documented involvement in the per-
ormance and interpretation of at least 300 studies (at least
alf with contrast enhancement), accrual of at least 40 h of
oursework devoted to CCT, and peer recognition to
nclude at least one of the following: 1) faculty lecturer for
t least two CME courses on the topic of CCT, 2)
ellowship/residency teaching activities, or 3) three or more
eer-reviewed publications in the area of CCT.
MR IMAGING
verview of CMR
ardiovascular magnetic resonance is well established in
linical practice for the diagnosis and management of a wide
pectrum of cardiovascular disease. Use of CMR represents
he specialized application of MR to the cardiovascular
ystem, employing specialized receiver coils, pulse se-
uences, and gating methods.
A brief overview of the technical aspects of CMR (24) is
ncluded to facilitate the understanding of the terms used in
he subsequent sections of this report and is not intended to
e comprehensive. A CMR scanner has six major compo-
ents. The magnet, which is usually superconducting, pro-
uces the static magnetic field whose strength is measured
n Tesla (e.g., 1.5-T or 3-T; 1.5-T is equivalent to 15,000
auss, and the Earth’s magnetic field is approximately 0.5
auss). A stable, homogeneous field is required about the
rea of interest. Resistive gradient coils within the bore of
he magnet produce the gradient fields, and the currents
ithin these coils are driven by the gradient amplifiers. The
erformance of the gradient system determines the speed of
he MR acquisition. A radiofrequency (RF) coil (antenna) is
oupled to an RF amplifier to excite the patient’s protons
ith RF pulses, and this (or another more localized surface
oil) is coupled to the receiver to measure the resultant
ignal. A computer is required to control the scanner and
enerate the images, which are then displayed in static,
ynamic (cine) modes. Post-processing tools are extensive
nd used both for quantitation and for image display.
Like echocardiography, MR is fundamentally safe and
oes not interfere with the electron shells involved in
hemical binding (e.g., DNA) that can be altered by
onizing radiation methods such as X-rays or CT. The
henomenon of MR is restricted to atomic nuclei with
npaired spin and includes hydrogen, carbon, oxygen, so-
ium, potassium, and fluorine; these latter elements are
arely used for imaging in clinical practice owing to their
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s used for clinical CMR spectroscopy, but the majority of
linical CMR imaging involves the hydrogen nucleus,
hich is abundant in water, fat, and muscle.
In the presence of an external magnetic field (primary
agnet), the hydrogen nucleus acts like a small magnet,
hich can align itself parallel to an external magnetic field,
rocessing about the field in a manner analogous to a
pinning top in a gravitational field. The frequency of
recession is 63 MHz for field strength of 1.5-T and is in
he RF range. Hydrogen nuclei can be excited by radio
aves only at this resonant frequency, which has the effect
f rotating the net magnetization vector by an amount
ermed the “flip angle.” After this excitation, the net
agnetization vector precesses around the direction of the
ain field, returning to its former position (relaxation)
uring which energy is transmitted as a radio signal that can
e detected by a receiver coil. The return of the net
agnetization vector to equilibrium has two components.
he vector component parallel to the main field relatively
lowly returns to equilibrium by interacting with surround-
ng molecules, and this is known as “T1 relaxation.” Recov-
ry of the vector component transverse to the field is more
apid and is termed “T2 relaxation.” The CMR images can
e weighted to show the distribution of T1 or T2 (proton
ensity). In order to localize the signals coming from the
ody, gradient magnetic fields are required that are switched
n and off at appropriate times.
An MR pulse sequence is a combination of RF pulses and
agnetic gradient field switches controlled by the scanning
omputer. For CMR, spin echo, gradient echo, steady-state
ree precession, phase velocity, and inversion recovery, pulse
equences are the most commonly used sequences. Spin
cho sequences are routinely used for multi-slice anatomical
maging; rapidly moving blood is typically suppressed/dark
hile gradient echo and steady-state free precession se-
uences are used for physiological assessment of cardiac
unction though cine acquisitions, and rapidly moving blood
s typically bright/white. Inversion recovery sequences are
ypically used in concert with MR contrast agents for
nfarction/viability imaging, where myocardium is purpose-
ully nulled/black, infarct is bright/white, and blood is an
ntermediate/gray. Images may be performed with ECG
ating/triggering (less preferred is peripheral pulse gating)
nd with respiratory suppression (breath holding or naviga-
or gating). This reduces image artefacts.
As compared with CCT in which images are acquired in
he axial plane and reconstructed in oblique orientations,
ith CMR, the data are often directly acquired in oblique
maging planes.
Some specialized sequences exist that have particular
pplication for the cardiovascular system. For example,
agnetic resonance angiography (MRA) is usually per-
ormed with 3D coverage of the vessel during a short
reath-hold and after intravenous injection of a gadolinium-
ased contrast agent. Gadolinium has seven unpaired elec- rrons in its outer shell, and it hastens T1 relaxation, thereby
ncreasing signal in the area of interest. Gadolinium alone is
ytotoxic, but not if chelated with diethylenetriamine pen-
aacetic acid (DTPA). Gadolinium-chelate has similar
harmacokinetic properties to iodinated X-ray contrast but
ith minimal nephrotoxicity and anaphylaxis risk. Several
DA-approved gadolinium-DTPA preparations have been
sed for over a decade, and the safety profile is far more
avorable than for iodinated contrast; however, it is not
resently FDA approved for use in the heart.
Myocardial perfusion CMR follows the effect of a first
ass of a bolus of intravenous gadolinium through multiple
lanes of the myocardium. Coronary MRI requires high
patial resolution. To characterize regional myocardial con-
raction, non-invasive “tagging” of the myocardium with a
rid at end-diastole and subsequent cine acquisition to
bserve tag deformation allows for calculation of myocardial
train. Finally, velocity mapping is a sequence used to
easure velocity and flow in blood vessels or within the
eart (somewhat analogous to Doppler echocardiography)
n which each pixel in the image displays the signal phase,
hich is encoded. Flow is calculated from the product of
ean velocity, and the vessel area is measured throughout
he cardiac cycle.
MR safety. The CMR method is very safe for the
ardiovascular patient, and no short- or long-term ill-effects
ave been demonstrated at current field strengths (less than
-T). Claustrophobia is problematic in over 2% of patients
25). A very important safety issue for CMR is the preven-
ion of ferromagnetic objects from entering the scanner area
s these will become projectiles (attractive force accelerates
s they approach the scanner). Common practice is to
pecifically check and verify that each medical device present
n patients is MR safe. Metallic implants such as hip
rostheses, mechanical heart valves, coronary stents, and
ternal sutures present no hazard since the materials used are
ot ferromagnetic (although a local image artifact will
esult). Care is required in patients with cerebrovascular
lips; however, specialist advice is needed for such patients.
atients with most pacemakers (implanted cardioverter-
efibrillators [ICDs]) retained permanent transvenous pace-
aker leads, and some other electronic implants (infusion or
onitoring devices) should not be scanned, although some
eports of success do exist in non–pacemaker-dependent
atients who are carefully monitored during the procedure
nd have device interrogation before and after CMR
25,26).
iological and clinical effects of CMR exposure. The
iological effects of CMR exposure will be considered under
he headings of attractive forces, heating, and stimulation.
he presence of a large magnetic field will impart forces on
ll ferromagnetic materials. The RF field, which is used for
xcitation, can induce heating of tissue and implanted
evices (particularly pacemaker leads or related devices).
he RF power deposition (also known as specific absorptionate [SAR]) is actively monitored in accordance with FDA
s
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July 19, 2005:383–402 ACCF/AHA Clinical Competence Statement on Cardiac CT and MRtandards. Finally, it is possible to stimulate sensitive tissues
uch as peripheral nerves owing to the rapidly changing
radient magnetic fields used to generate images. Myocar-
ial stimulation has not been described with current hard-
are. Clinical CMR hardware has reached the limit for
timulation of peripheral nerves, and clinical imaging ap-
roaches are designed to avoid such stimulation.
MR Laboratory Requirements
eneral considerations. Defining the specific require-
ents for a valid CMR laboratory is beyond the scope of
his document, which is concerned about accreditation for
hysicians. However, some general aspects of the appropri-
te MRI environment can be considered.
A continuous QC program must be established for all
MR units with the assistance of a qualified medical
hysicist and a Level 3-trained physician coordinator (levels
f training are described in the following text). The scanners
ust be staffed by CMR technologists with appropriate
ackground and/or training in CMR. A qualified medical
hysicist should periodically check equipment calibration
signal-to-noise ratio levels and image quality factors). A
afety program should be active, and should include con-
rolled access to the CMR equipment and training pro-
rams in CMR safety for all personnel. In addition, patient
afety should be assured through a well documented screen-
ng and evaluation program for implanted devices, admin-
stered by the CMR medical director with ongoing docu-
entation, training, and evaluation by nursing personnel
erforming screening procedures.
ONITORING AND ANCILLARY HARDWARE. The scanner
hould have appropriate monitoring hardware for ECG
hythm, non-invasive blood pressure measurement, and
ulse oximetry determination during CMR procedures. If
tress cardiac studies are performed using high-dose dobu-
amine, real-time image reconstruction and display or an
n-the-fly display of cine images allowing rapid assessment
f global and regional function to monitor the signs of
yocardial ischemia should be available. For stress myocar-
ial perfusion studies, CMR-compatible infusion pumps are
ecessary for the infusion of adenosine and possibly dipy-
idamole (if administered in the CMR imaging room), and
n appropriate patient monitoring system is required. Nurs-
ng and physician personnel should be trained in the
dministration, monitoring, and side effects of the pharma-
ologic stress agents used by the center. Some patients
enefit from supplemental oxygen using low flow nasal
rongs during the study. A CMR-compatible power injec-
or is necessary for gadolinium contrast-enhanced myocar-
ial perfusion studies and preferred for contrast-enhanced
RA procedures. The CMR personnel should be trained in
he recognition and management of reactions to CMR
ontrast media, to sedatives, and to other drugs adminis-
ered as part of the CMR procedure. iOST-PROCESSING AND DATA ANALYSIS. The CMR labo-
atory should have the capabilities for post-processing CMR
ata, including LV and RV function determination, analysis
f myocardial perfusion images, cine review of myocardial
unction studies, and a full 3D processing and display
ystem for MRA studies.
linical indications for CMR. A comprehensive review of
he clinical indications for CMR is beyond the scope of this
eport. Interested readers are referred elsewhere (24). A
rief overview of broad clinical indications is presented in
he text. These are intended to serve as a general guide for
MR training to include a broad spectrum of pathologic
ases inclusive of these indications.
MR in ischemic heart disease: regional and global func-
ion, perfusion, viability, and coronary angiography. Be-
ause of its inherent 3D capabilities, high spatial and
emporal resolution, and high contrast resolution, CMR is
idely recognized as the “reference standard” for the quan-
itative assessment of RV and LV volumes, EF, mass, and
egional ventricular function. The CMR tagging techniques
re unique among all modalities for determination of
yocardial strain.
Use of CMR is a highly accurate and reproducible
oninvasive method for measuring EF, LV volumes, and
V mass, and also to assess LV structure and function (27).
sually bright blood gradient echo sequences, with 15 s of
reath-hold, are used to cover the entire LV with short-axis
iews from the mitral plane. Also, the sample size needed to
etect LV parameter changes in a clinical trial is far less than
ther imaging modalities; this markedly reduces the time
nd cost of patient care and pharmaceutical trials (28).
egional LV function can be measured as in echocardiog-
aphy using visual assessment of endocardial motion but
ore frequently systolic wall thickening. Beek et al. (29)
emonstrated the relationship between functional recovery
nd transmural necrosis using visual assessment of systolic
ndocardial motion and wall thickening. Previous studies
sed similar methods to document similar relationships
oth in the acute (30) and chronic (31) myocardial infarc-
ion (MI) settings.
Although physical exercise within the confines of the
agnet is technically difficult, there have been extensive
tudies of pharmacologic CMR stress. Both beta-agonist
e.g., dobutamine) stress examinations for inducible wall
otion abnormalities and stress vasodilator (e.g., adenosine)
n combination with first passage of a small dose of
adolinium-DTPA for assessment of myocardial perfusion
ave been shown to be accurate for detecting CAD. As the
T-segment is distorted/uninterpretable in the CMR envi-
onment, close clinical patient monitoring is required. Re-
ent progress in the diagnosis and treatment of CAD has
ntensified the need to differentiate viable from non-viable
yocardium with accuracy and high spatial resolution. Use
f CMR has been demonstrated to be an effective technique
o assess myocardial viability (32). The development of
nversion recovery gradient echo imaging techniques pro-
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alities created by microvascular obstruction from myocardial
yper-enhancement secondary to myocardial necrosis
33,34). The prognostic value of contrast-enhanced MRI in
atients with acute MI is well established (35). However,
ecent work on the specific utilization of this technique for
he purpose of predicting local functional recovery after
cute MI (29,30,36) has further expanded its potential
tilization.
Acute and chronic MI can be detected with high accuracy
nd sensitivity using delayed enhancement CMR with an
nversion recovery sequence. The inversion time is chosen to
ull/suppress normal myocardial signal with resultant bright
ignal in areas of fibrosis where gadolinium-DTPA will
oncentrate. Both the delayed-enhancement technique and
ow-dose dobutamine have been shown to have great utility
or the assessment of myocardial viability among patients
eing considered for revascularization.
The application of CMR coronary angiography for the
ssessment of the course of anomalous coronary arteries and
oronary artery bypass graft (CABG) patency is well estab-
ished. The use of CMR coronary angiography for native
essel integrity has been shown to be feasible, especially for
he proximal and mid-portions of the major coronary
essels, but it remains technically demanding in the branch
essels owing to their smaller size, tortuosity, complex 3D
natomy, and cardiac and respiratory motion artifacts
9,37,38). Using current 3D acquisitions and optimized
equences, good results for the exclusion of multivessel
isease have been shown. Currently available intracoronary
tents appear to be CMR “safe,” but they can result in a
ocalized signal artifact. Each new stent material requires
valuation for CMR safety.
MR in non-ischemic cardiomyopathies. The non-
schemic cardiomyopathies include a variety of disorders in
hich the primary pathology directly involves the myocar-
ium. Use of CMR is proving increasingly valuable in the
dentification and management of these conditions—
ncluding delineation of hypertrophy and fibrosis for hyper-
rophic cardiomyopathy, iron deposition in hemochromato-
is, fatty or fibrous replacement in arrhythmogenic RV
ysplasia, and myocarditis. The CMR technique is very
ffective for monitoring the severity of LV hypertrophy in
ypertrophic cardiomyopathy and for the monitoring of
entricular volumes in dilated cardiomyopathy.
MR in pericardial disease. Both CMR and CCT accu-
ately define pericardial thickening and circumferential and
oculated pericardial effusions. Although CCT has the
dvantage of pericardial calcium identification, CMR has
he advantage of being able to depict and quantify the
unctional abnormalities, which may be associated with
ericardial disease, and for demonstrating physiologic signs
f ventricular interdependence with calcified pericardium.
MR in valvular heart disease. Although echocardiogra-
hy remains the preferred imaging modality for the routine
etermination of valve morphology and flow abnormalities, fMR is starting to be utilized in the care of patients with
egurgitant lesions. Valvular regurgitation is usually recog-
ized as a signal void on cine CMR. A quantitative
ssessment of single-valve lesions can be obtained by calcu-
ating the regurgitant volume from the difference of RV and
V stroke volumes or the use of phase-velocity data from
he ascending aorta and main pulmonary artery to calculate
egurgitant volumes. Also, CMR has been shown to provide
ata for the estimation of gradients and areas in mitral and
ortic stenosis.
MR for CHD patients. The CMR technique is a very
mportant resource for the evaluation of known or suspected
HD in children and adults. Assessment of CHD was one
f the first clinical indications for the performance of CMR,
nd its utility in the assessment of CHD has grown with the
evelopment of CMR technology. Although echocardiog-
aphy is often the initial imaging modality used in the
ssessment of CHD, CMR can provide accurate 3D assess-
ent of cardiac structure and blood flow, especially valuable
or patients with suboptimal acoustic windows. In addition,
specially in adults, CMR may be a better method for
ssessing the great vessels and complex CHD.
A graduate of an ACGME-approved fellowship in car-
iovascular diseases or residency in nuclear medicine or
adiology should be able to determine the appropriate
ndications for CMR in CHD assessment, knowing
hether to refer to CMR or another imaging modality. This
s especially true in the assessment of pediatric CHD
atients for whom echocardiography is not sufficient. The
enefits of CMR in children must be balanced against the
ccasional requirement of deep sedation or general anesthesia.
cquired Vascular Disease
se of CMR is particularly helpful for vascular lumen
maging because of its ability to generate projectional MRA.
hese can be generated either without contrast (time-of-
ight technique) or contrast-enhanced with intravenous
adolinium. Consequently, it is well suited for use in
atients with contraindications to X-ray contrast due to
llergy or renal insufficiency. In addition to angiography, the
ide variety of soft tissue contrast available on CMR
proton density, T1, T2, lipid-saturation) can be applied to
ascular imaging to assess features of vessel wall such as
ematoma/thrombus, inflammation, and atherosclerotic
laque. In addition to morphologic imaging of blood
essels, phase-contrast imaging (velocity mapping) can be
sed to quantify blood flow. Vascular CMR is beyond the
cope of this document.
echnical aspects of the CMR examination. A CMR
hysician must be skilled in all technical aspects of perfor-
ance of the CMR examination. This includes a thorough
nowledge of available pulse sequences and the indications
or their use. Sequences the CMR physician must be
amiliar with include:
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gradient echo, steady-state free precession) for assess-
ment of function and anatomy.
. Fast, spin echo and half Fourier spin echo, black-blood
sequences, for assessment of anatomy.
. Phase contrast sequences for calculation of blood flow,
shunt ratios, valve regurgitant fraction, and gradient
assessment.
. Contrast-enhanced MRA techniques for assessment of
great vessels.
. Delayed hyperenhancement imaging, dobutamine wall
motion stress, and vasodilator stress perfusion imaging,
tagging, and post-processing.
he CMR physicians should be familiar with the various
ypes of coils available for cardiac imaging, and how they
an be used in their patient populations (pediatric vs. adult),
s well as K-space acquisition (symmetric, asymmetric,
entric), and methods of ECG gating. The latter is espe-
ially important as the placement of leads may vary from the
orm in patients with CHD.
In addition, the CMR physician must be familiar with
he use of gadolinium-based MRI contrast agents including
heir indications and adverse reactions. The CMR physician
hould also be well versed in the treatment of the contrast
eactions, including hives, wheezing, hemodynamic re-
ponses, and anaphylaxis, although rare. A thorough knowl-
dge of appropriate doses of treatment medication, depend-
ng upon one’s patient population (adult vs. pediatric), is
rucial.
inimal Knowledge and Skills Required for
MR Expertise
he CMR training recommendations have been published
y three societies: ACR, ACC, and SCMR (1–3). The
CC and SCMR recommendations directly address the
oals of general training and are outlined by Task Force 12
f the COCATS-2 (1). The purpose of general training is
o provide the practicing physician or resident/fellow in
raining with the working knowledge of CMR methods in
rder to facilitate patient care and management. It is
ecommended that all trainees in cardiovascular diseases and
adiology have CMR exposure for at least one month or its
quivalent when integrated with other activities during the
ractice of cardiovascular medicine or radiology. From a
ractical perspective, many clinicians in practice may not
ave access to CMR-enabled equipment or qualified (Level
or Level 3) mentors. It is recommended that candidates
ake this opportunity to supplement their education through
ecture material, didactic reading, and journal or electronic
edia review. The committee reviewed guidelines set forth
or other imaging modalities (for example, echocardiogra-
hy, COCATS2) (1), and the caseload required reflects the
eed for increased time to learn the interpretation skills
ecessary but decreased physical training (for example,
ransducer time). cDuring general training in cardiovascular diseases and
adiology, physicians should obtain a basic understanding of
R physics, which include the principles of image con-
truction, T1 and T2 relaxation, measurements of blood
ow, determinations of anatomy, image contrast, function,
iability, myocardial perfusion, CMR contrast agents, and
etabolism. Review of the indications and side effects of
MR contrast materials should occur along with exposure
o proper receiver coil selection, methods of cardiac gating
nd triggering (e.g., ECG and peripheral pulse), respiratory
otion suppression (e.g., breath-hold and navigators), and
ources of image artifacts (e.g., motion, arrhythmias, and
etal objects). Also, understanding of the contraindications
o CMR, and the safety of devices within the MR environ-
ent, should be reviewed. Recognition of the sensitivity,
pecificity, diagnostic accuracy, costs, indications, and prog-
ostic capability is to be accomplished in general training as
his information is important for understanding the proper
linical use of CMR.
All cardiovascular and radiology trainees should actively
articipate in CMR interpretation under the supervision of
qualified (preferably Level 3) physician-mentor. Some
upervision by an expert non-CMR physician can suffice for
ome of the basics of CMR, including workstation expo-
ure, tomographic imaging training, and so on. Correlative
essions should be performed with other imaging modalities
echocardiography, nuclear cardiology, CCT, and invasive
-ray) as well as historical, physical examination, and
aboratory and hemodynamic data. The types of procedures
eviewed should include those directed toward assessments
f the cardiovascular system, incorporating measures of
tructure, tissue characterization, function, myocardial per-
usion, delayed hyperenhancement imaging, blood flow,
laque characterization, and angiography of the thoracic
orta and bypass grafts incorporating vessels within these
erritories. Procedures involving the use of intravenous
ontrast material should be included. A minimum of 50
uch cases should be performed. This might include review
nd interpretation from an established teaching file of
revious CMR cases or those administered from electronic
edia. Hands-on experience is not necessary for general
raining.
ormal training to achieve competence in CMR. The
ecommendations for all levels of training below represent a
umulative experience, and it is expected that for many
racticing clinicians the training will not be continuous.
ime spent at didactic CME courses that specifically target
MR can also contribute to the total time. Due to the
dvancement in the sophistication and widespread availabil-
ty of electronic training medias, the committee felt that
ome training can now be obtained outside the laboratory
etting. However, for all Level 2 and Level 3 requirements,
inimum time in a laboratory supervised by a Level 2 or
evel 3 CMR physician is half of the time listed, with the
ther half garnered by supervised time, CME and other
ourses, case studies, CD/DVD training, and time spent at
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ACCF/AHA Clinical Competence Statement on Cardiac CT and MR July 19, 2005:383–402ajor medical meetings devoted to performance of CMR,
o cite just a few examples. The caseload recommendations
ight include studies from an established teaching file,
revious CMR cases or electronic/on-line CME. Although
his is less “in-laboratory” time than that listed in both the
OCATS and the SCMR published recommendations
1,3), these other documents also include training time for
eripheral imaging.
For all levels of competence, it is expected that the
andidate will attend lectures on the basic concepts of CMR
nd include parallel self-study reading material. A basic
nderstanding of CMR should be achieved, including the
hysics of MRI in general and of CMR in particular. The
ontent should include the basics of CMR scan perfor-
ance, CMR safety issues, and basics of CMR interpreta-
ion as compared with other cardiovascular imaging modal-
ties including echocardiography, nuclear medicine, CCT,
nd invasive cardiac X-ray angiography.
EVEL 1 TRAINING. Level 1 is defined as the minimal
ntroductory training for familiarity with CMR, but this
xposure is not sufficient for independent interpretation of
MR images. The individual should have intensive expo-
ure to the methods and the multiple applications of CMR
or a period of at least four weeks. This should provide a
asic background in CMR for the practice of adult cardi-
logy or for general radiology.
During this cumulative four-week experience, individuals
hould have been actively involved in CMR interpretation
nder the direction of a qualified (Level 2- or Level
-trained) physician-mentor. For all studies in which other
ardiovascular imaging methods are also available, correla-
ion with CMR findings and interpretation should be
ncluded. Studies should consist as much as possible within
he range of pathologies outlined in the previous text.
ndependent performance of CMR is not required for Level
training, and the mentored interpretive experience of 50
ases may include studies from an established teaching file
r previous CMR cases.
EVEL 2 TRAINING. Level 2 training is defined as the
inimum recommended instruction for a physician to
ndependently perform and interpret CMR. This is an
xtension of Level 1 training and is intended for individ-
als who wish to practice or actively be involved with
MR performance and interpretation. The minimum
equirement is three months of cumulative experience,
ith a minimum time in a program supervised by a Level
or Level 3 CMR physician over a period of six weeks,
ith the other six weeks garnered by supervised time,
ME and other courses, case studies, CD/DVD training,
ime spent at major medical meetings devoted to perfor-
ance of CMR, and so forth. In-lab training time is
efined as a minimum of 35 h/week.
Didactic instruction as well as tested self-study should be
dministered in MR physics, MR applications and indica-
ions, and clinical interpretation. Didactic studies should ponsist of more advanced lectures and reading materials as
ell as formal case presentations and should include the
ollowing:
. Physics—trainees should receive didactic lectures from a
CMR-trained physician and/or physicist on the basic
physics of MR. Topics should include:
a. Image formation, including K-space (implications of
symmetric and asymmetric, spiral, radial K-space
sampling) gradient echo imaging, spin echo imaging,
echo planar imaging, fast spin echo imaging, and 2D
and 3D imaging.
b. Physics implicating patient safety, including energy
deposition, specific absorption rate (SAR) limits and
possible neurological effects, and heating and motion
of metallic implants.
c. Specialized imaging sequences, including flow and
motion, phase imaging, time-of-flight, respiratory
gating, contrast agents, and MR tagging.
d. Hardware components, including basic elements of
gradient coil design, receiver coils, and digital
sampling.
. Applications and Indications—didactic activities should
include discussion of the sensitivity, specificity, accuracy,
utility, costs, and disadvantages of all CMR techniques
and applications. The following techniques should be
covered in the didactic program:
a. ECG and peripheral pulse gating and triggering,
including timing of image acquisition within the R-R
interval, motion artifacts and their effects upon image
interpretation, velocity calculation, and other physio-
logical quantifications.
b. Respiratory motion suppression, including its uses
and effects upon image interpretation.
c. Stress pharmacologic agents and their application to
CMR, including adequate monitoring under CMR
performance and reversal of stress conditions.
d. Imaging of structure and tissue characterization (T1,
T2, spin echo imaging), tissue (inversion recovery,
saturation recovery methods) and fat suppression.
e. Imaging of ventricular function (cine and tagged cine
MRI).
f. Flow imaging (velocity-encoded techniques).
g. First-pass perfusion and delayed contrast-enhancement
imaging (gadolinium-enhanced techniques).
h. Image processing for creating of angiographic images,
velocity and flow calculation, function parameters
(EF, myocardial mass, and so on)
i. Clinical instruction—a Level 3 CMR mentor must be
able to provide the trainee with instruction in ade-
quate image interpretation. Topics addressed should
include those listed above.
During this training experience, each candidate should
ctively participate in CMR study interpretation under the
irection of a qualified (preferably Level 3-trained)
hysician-mentor. The candidate should be involved with
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t least 50 necessitated the candidate being physically
resent and involved in the acquisition and interpretation of
he case. Cases should reflect the broad range of anticipated
athology.
Each physician should receive didactic lectures from a
MR mentor and/or physicist on the basic physics of MR
n general and on CMR in particular. Lectures should
nclude discussions of anatomy, contrast administration and
inetics, CMR safety, and the principles of 3D imaging and
ost-processing. Finally, the physician should be thoroughly
cquainted with the many morphologic and pathophysio-
ogic manifestations and artifacts demonstrated on CMR
mages.
Table 6 provides a summary of the overall requirements
or CMR Level 1 and Level 2 training.
EVEL 3 TRAINING. Level 3 training represents the highest
evel of exposure/expertise that would enable an individual
o serve as director of an academic CMR section or director
f an independent CMR facility. This individual would be
irectly responsible for QC and training of technologists
nd to be a mentor to other physicians seeking such
raining. The minimum cumulative training period should
e 12 months and include all the didactic requirements of
evel 2 training as well as participation in CMR study
nterpretation under the direction of a qualified (Level
-trained) physician-mentor. In-lab training time is defined
s a minimum of 35 h/week. The candidate should be
nvolved with interpretation of at least 300 CMR examina-
ions in which at least 100 involved the candidate as the
rimary operator and interpreter. Cases should reflect the
road range of pathology expected in a CMR practice.
In addition to the recommendations for Level 1 and
evel 2 training, Level 3 training should include active
articipation in an ongoing laboratory, clinical research, or
eaching. This also requires continued and documented
linical and educational experiences. These requirements are
isted in Table 7. Cooperation between radiology and
ardiovascular disease colleagues is encouraged. Addition-
lly, supervising CMR physicians should have appropriate
nowledge of alternative imaging methods, including the
se and indications for specialized procedures encompassing
chocardiography and vascular ultrasound, CCT, and nu-
lear medicine/PET studies.
pecial training in CHD requirements. A physician with
evel 2 or Level 3 training in CMR should be capable of
able 6. Requirements for CMR Study Performance and Interpr
Cumulative Duration of Training
Minimu
E
evel 1 1 month
evel 2 3 months*
evel 3 1 year*
This represents cumulative time spent interpreting, performing, and learning about
epresent supervised laboratory experience. This can include time spent at educational cours
ecommendations may include studies from an established teaching file, previous CMR caecognizing simple CHD. However, as with echocardiog-
aphy (39), few adult cardiology training programs have a
ufficient case load and case mix of complex lesions to ensure
n adequate level of training. Although those trained in
MR may be able to recognize the presence of a complex
ongenital lesion, many MRI programs are unable to
rovide enough experience to trainees to develop the special
kills necessary to evaluate complex CHD, post-surgical
ppearance, and post-surgical complications. Competence
n performing and/or interpreting CMR in pediatric and
dult patients with complex CHD requires the basic knowl-
dge of MRI physics, instrumentation, anatomy, physiol-
gy, and pathology for CMR interpretation. Practitioners
ho wish to perform CMR in patient populations with
dult and pediatric CHD need special experience. A rec-
mmended case load (as part of the total number recom-
ended for competence) for Level 2 is 25 cases, and Level
is 50 cases, with additional 20 cases annually to maintain
ompetence. Of note, case mix is an important aspect of the
raining experience.
The CMR physician must also be well trained in the
ollowing:
or the pediatric CHD patient:
. Cardiac structure and physiology during growth and
development from infancy to adulthood.
. Spectrum of acquired heart disease in the pediatric age
group.
. Spectrum of surgical palliation and surgical repair of
CHD and its manifestations on CMR.
. Spectrum of catheter-based interventions for CHD and
its manifestations in the CMR examination.
. Indications for performance of CMR in the pediatric
patient, including the risks of general anesthesia and
conscious sedation in relationship to the benefit of
diagnostic information obtained for a given purpose.
or the adult CHD patient:
. Anatomic and physiologic spectrum of CHD and its
manifestations in the adult.
. Spectrum of surgical palliation and repair for CHD and
its manifestations on CMR.
. Spectrum of catheter-based interventions for CHD and
its manifestations in the adult CMR.
. Sequelae of surgical palliation and repair and catheter-
based interventions and their presence and manifesta-
tion in CMR.
n to Achieve Level 1, 2, and 3 Training
otal Number of Mentored
inations Performed
Minimum Number of Mentored
Examinations Interpreted
— 50†
50 150†
100 300†
, and need not be a consecutive block of time, but at least 50% of the time shouldetatio
m T
xam
CMR
es on the topic. Training time is defined as a minimum of 35 h/week. †The caseload
ses, and electronic/on-line CME.
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the underlying congenital lesion.
ROOF OF TRAINING. Documentation of training can be
chieved by means of letters or certificates from the director
f a fellowship training program or from individuals who are
evel 2 or Level 3 qualified in hospital-based or indepen-
ent imaging centers or clinics (Table 8). This documenta-
ion should state the dates of training and that the candidate
ad successfully achieved or surpassed each of the training
lements (Levels 1, 2, and 3).
Practicing physicians can achieve appropriate training in
MR without enrolling in a full-time formal training
rogram. However, the same prerequisite medical knowl-
dge, medical training, and goals as previously outlined are
equired. Directly working with a mentor on an ad-hoc basis
s acceptable, but formalized time of cumulative exposure
or Levels 1 through 3 competence will be maintained.
urrently, a practicing physician seeking this training
hould have completed an ACGME-approved cardiovascu-
ar diseases fellowship, nuclear medicine or general radiol-
gy residency, and hold a valid license to practice.
aintaining CMR expertise. Individuals, even after a
ormal fellowship training period, are required to continue
aintenance of expertise in CMR. Those who are currently
t Level 1 or Level 2 training can advance to the next level
y pursuing independent advanced studies either from an
cademic center or an independent center specializing in
MR. No formal mechanisms currently exist regarding
ssurance of maintaining competence. The field of CMR
as expanded rapidly, and ongoing procedural and technical
mprovements are expected.
able 7. Requirements for Level 2 and Level 3 CMR Training C
Level 2
nitial experience ● Board certification or eligibility, valid me
and completion of a 3-month (cumulativ
residency or fellowship in CMR, AND
● 150 CMR examinations in which 50 wh
candidate is physically present, involved i
acquisition and interpretation of the case
● Completion of 30 h of courses related to
general and/or CMR in particular
ontinuing education 30 h of coursework every 36 months in CM
able 8. Documentation and Maintenance of Clinical Competen
Documentation of
Competence Training Gu
raining completed after
July 1, 2008
Level 2 training
raining completed before
July 1, 2008
Level 2 training OR interpretation of at
the candidate is physically present, in
pretation of the case) and attendance
Level 3 training OR interpretation of at l
the candidate is physically present, in
pretation of the case) and attendance i
acknowledged teacher of CMRaintenance of competence Performance and/or interpretation of 50 (LevMaintenance of CMR expertise requires both ongo-
ng continuing education and regular performance and
nterpretation of clinical and research CMR examinations.
hysicians should periodically attend postgraduate courses
nd workshops that focus on clinical applications of CMR,
specially those that emphasize new and evolving techniques
nd developments. In addition, physicians should seek to
ompare the quality, completeness, and results of their own
xaminations with those presented at scientific meetings
nd in professional publications. Level 2- and Level
-trained individuals will be required to document category
CME in the area. Recommended CME for maintaining
evel 2 training is 30 h devoted to CMR over a 3-year
eriod. Recommended CME for maintaining Level 3 train-
ng is 60 h devoted to CMR over a 3-year period. It is also
ecommended that at least 50 CMR examinations each year
e performed and interpreted for those at Level 2 and at
east 100 CMR examinations for those maintaining Level 3
raining.
rior experience to qualify for Levels 2 and 3 training for
MR. It is expected that a substantial number of practi-
ioners from radiology, cardiology, and nuclear medicine
ave been performing CMR studies for some time prior to
he creation of these guidelines. These practitioners can
ualify for completion of Level 2 or Level 3 training by
aving achieved the minimum criteria set forth below by
uly 1, 2008, as well as board certification and completion of
n ACGME-approved radiology residency or cardiology
ellowship, or at least six months’ formal training in CMR.
Level 2 training: there should be substantive activities in
al Competence
Level 3
license,
cialty
e
D
in
● Board certification or eligibility, valid medical
license, and completion of a 12-month (cumulative)
specialty residency or fellowship in CMR, AND
● 300 CMR examinations in which 100 where the
candidate is physically present, involved in the
acquisition and interpretation of the case, AND
● Completion of 60 h of courses related to MR in
general and/or CMR in particular
60 h of coursework every 36 months in CMR
CMR
nes Proof of Competence
Letter or certification from training
supervisor OR letter attesting to
competence from Level 2- or 3-
trained physician
150 studies (in which 50 where
d in the acquisition and inter-
least 30 h of devoted CME
00 studies (in which 100 where
d in the acquisition and inter-
ast 60 h of devoted CME, andlinic
dical
e) spe
ere th
n the
, AN
MRce in
ideli
least
volve
in at
east 3
volve
n at leel 2) or 100 (Level 3) cases/yr
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ent in the performance and interpretation of the last three
ears.
Level 3 training: activities in CMR should include
unning a CMR laboratory, with documented involvement
n the performance and interpretation of at least 300 CMR
tudies; attendance in at least 60 h of CME devoted to
MR, and being an acknowledged CMR instructor as a
aculty member teaching CME courses on the topic; or
MR teaching activities with at least three published
tudies in the area of CMR. Proof of competence can be
btained by a letter of attestation by a Level 3 physician who
as overread the studies or a letter or certificate from one’s
raining supervisor (Table 8).
TAFF
merican College of Cardiology
hristine W. McEntee, Chief Executive Officer
isa Bradfield, Senior Specialist, Clinical Policy & Docu-
ments
merican Heart Association
. Cass Wheeler, Chief Executive Officer
athryn A. Taubert, PhD, FAHA, Senior Science Advisor
EFERENCES
1. Pohost GM, Kim RJ, Kramer CM, Reichek N. Task Force 12:
Training in Cardiovascular Magnetic Resonance. Available at: http://
www.acc.org/clinical/training/COCATS2.pdf. Last update 2002.
2. Weinreb JC, Larson PA, Woodard PK, et al. American College of
Radiology Clinical Practice Statement on noninvasive imaging. Radi-
ology 2005;235:723–7.
3. Society for Cardiovascular Magnetic Resonance (SCMR) Clinical
Practice Committee. Guidelines for credentialing in cardiovascular
magnetic resonance (CMR). J Cardiovasc Magn Reson 2000;2:233–4.
4. Bell MR, Lerman LO, Rumberger JA. Validation of minimally
invasive measurement of myocardial perfusion using electron beam
computed tomography and application in human volunteers. Heart
1999;81:628–35.
5. Rumberger JA. Use of ultrafast (cine) X-ray computed tomography in
cardiac and cardiovascular imaging. In: Giuliani ER, editor. Mayo
Clinic Practice of Cardiology. St. Louis, MO: Mosby, 1996:303–24.
6. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD.
Prediction of coronary events with electron beam computed tomogra-
phy. J Am Coll Cardiol 2000;36:1253–60.
7. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography
coronary artery calcium and cardiac events: a 37-month follow-up of
5,635 initially asymptomatic low- to intermediate-risk adults. Circu-
lation 2003;107:2571–6.
8. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ.
Prognostic value of cardiac risk factors and coronary artery calcium
screening for all-cause mortality. Radiology 2003;228:826–33.
9. Budoff MJ, Achenbach S, Duerinckx A. Clinical utility of computed
tomography and magnetic resonance techniques for noninvasive cor-
onary angiography. J Am Coll Cardiol 2003;42:1867–78.
0. Lu B, Shavelle DM, Mao S, et al. Improved accuracy of noninvasive
electron beam coronary angiography. Invest Radiol 2004;39:73–9.
1. Ropers D, Baum U, Pohle K, et al. Detection of coronary artery
stenoses with thin-slice multi-detector row spiral computed tomogra-
phy and multiplanar reconstruction. Circulation 2003;107:664–6.
2. Hoffmann U, Moselewski F, Cury RC, et al. Predictive value of
16-slice multidetector spiral computed tomography to detect signifi-
cant obstructive coronary artery disease in patients at high risk for
coronary artery disease: patient-versus segment-based analysis. Circu-
lation 2004;110:2638–43.3. Leta R, Carreras F, Alomar X, et al. [Non-invasive coronary angiog-
raphy with 16 multidetector-row spiral computed tomography: a
comparative study with invasive coronary angiography]. Rev Esp
Cardiol 2004; 7:217–24.
4. Nasir K, Budoff MJ, Post WS, et al. Electron beam CT versus helical
CT scans for assessing coronary calcification: current utility and future
directions. Am Heart J 2003;146:969–77.
5. Hunold P, Vogt FM, Schmermund A, et al. Radiation exposure
during cardiac CT: effective doses at multi-detector row CT and
electron-beam CT. Radiology 2003;226:145–52.
6. Morin RL, Gerber TC, McCollough CH. Radiation dose in com-
puted tomography of the heart. Circulation 2003;107:917–22.
7. Jakobs TF, Becker CR, Ohnesorge B, et al. Multislice helical CT of
the heart with retrospective ECG gating: reduction of radiation
exposure by ECG-controlled tube current modulation. Eur Radiol
2002;12:1081–6.
8. Kuettner A, Beck T, Drosch T, et al. Diagnostic accuracy of
noninvasive coronary imaging using 16-detector slice spiral computed
tomography with 188 ms temporal resolution. J Am Coll Cardiol
2005;45:123–7.
9. Mollet NR, Cademartiri F, Krestin GP, et al. Improved diagnostic
accuracy with 16-row multi-slice computed tomography coronary
angiography. J Am Coll Cardiol 2005;45:128–32.
0. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized
myocardial segmentation and nomenclature for tomographic imag-
ing of the heart: a statement for healthcare professionals from the
Cardiac Imaging Committee of the Council on Clinical Cardiology
of the American Heart Association. Circulation 2002;105:539 – 42.
1. Baik HK, Budoff MJ, Lane KL, Bakhsheshi H, Brundage BH.
Accurate measures of left ventricular ejection fraction using electron
beam tomography: a comparison with radionuclide angiography, and
cine angiography. Int J Card Imaging 2000;16:391–8.
2. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O’Brien KD.
HMG CoA reductase inhibitor (statin) and aortic valve calcium.
Lancet 2002;359:1125–6.
3. Benatar NA, Cronin BF, O’Doherty MJ. Radiation dose rates from
patients undergoing PET: implications for technologists and waiting
areas. Eur J Nucl Med 2000;27:583–9.
4. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for
cardiovascular magnetic resonance (CMR): Consensus Panel report.
Eur Heart J 2004;25:1940–65.
5. Kuijpers D, Janssen CH, van Dijkman PR, Oudkerk M. Dobutamine
stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular
magnetic resonance in patients suspected of myocardial ischemia. Eur
Radiol 2004;14:1823–8.
6. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K.
Magnetic resonance imaging and cardiac pacemaker safety at 1.5-
Tesla. J Am Coll Cardiol 2004;43:1315–24.
7. Task Force of the European Society of Cardiology, in collaboration
with the Association of European Paediatric Cardiologists. The
clinical role of magnetic resonance in cardiovascular disease. Eur
Heart J 1998;19:19–39.
8. Semelka RC, Tomei E, Wagner S, et al. Normal left ventricular
dimensions and function: interstudy reproducibility of measurements
with cine MR imaging. Radiology 1990;174:763–8.
9. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-enhanced
magnetic resonance imaging for the prediction of regional functional
improvement after acute myocardial infarction. J Am Coll Cardiol
2003;42:895–901.
0. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd
RM. Transmural extent of acute myocardial infarction predicts
long-term improvement in contractile function. Circulation 2001;
104:1101–7.
1. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced
magnetic resonance imaging to identify reversible myocardial dysfunc-
tion. N Engl J Med 2000;343:1445–53.
2. Goldman MR, Brady TJ, Pykett IL, et al. Quantification of experi-
mental myocardial infarction using nuclear magnetic resonance imag-
ing and paramagnetic ion contrast enhancement in excised canine
hearts. Circulation 1982;66:1012–6.
3. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA.
Regional heterogeneity of human myocardial infarcts demonstrated by
33
3
3
3
3
A
T
D
D
D
D
D
D
D
D
D
D
D
D
T
a
p
402 Budoff et al. JACC Vol. 46, No. 2, 2005
ACCF/AHA Clinical Competence Statement on Cardiac CT and MR July 19, 2005:383–402contrast-enhanced MRI: potential mechanisms. Circulation
1995;92:1117–25.
4. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time
course of microvascular obstruction and tissue injury after acute
myocardial infarction. Circulation 1998;98:1006–14.
5. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of
microvascular obstruction by magnetic resonance imaging in patients
with acute myocardial infarction. Circulation 1998;97:765–72.
6. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of
contrast-enhanced magnetic resonance imaging in predicting improve-
ment of regional myocardial function in patients after acute myocardial7. Woodard PK, Li D, Haacke EM, et al. Detection of coronary stenoses
on source and projection images using three-dimensional MR angiog-
raphy with retrospective respiratory gating: preliminary experience.
AJR Am J Roentgenol 1998;170:883–8.
8. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance
angiography for the detection of coronary stenoses. N Engl J Med
2001;345:1863–9.
9. Quinones MA, Douglas PS, Foster E, et al. ACC/AHA clinical
competence statement on echocardiography: a report of the American
College of Cardiology/American Heart Association/American College
of Physicians-American Society of Internal Medicine Task Force oninfarction. Circulation 2002;106:1083–9. Clinical Competence. J Am Coll Cardiol 2003;41:687–708.
ppendix. ACCF/AHA Writing Committee to Develop a Clinical Competence Statement on Cardiac Imaging With Computed
omography and Magnetic Resonance—Relationships With Industry
Name Consultant Research Grant
Scientific Advisory
Board Speaker’s Bureau
Steering
Committee
Stock
Holder
r. Matthew J. Budoff None None None ● General Electric None None
r. Mylan C. Cohen None None None None None None
r. Mario J. Garcia None ● Philips Medical
Systems
● Bristol Myers
Squibb
None ● GE Healthcare
● Bristol Myers
Squibb
None None
r. John McB. Hodgson ● Volcano
Therapeutics
● Bristol Myers
Squibb
● Volcano
Therapeutics
● Medicines
● Guillford
● Radi
● Volcano
Therapeutics
r. W. Gregory Hundley None ● Mallinckrodt
● Bracco
Diagnostics
None ● Bracco
Diagnostics
● Pfizer
None None
r. Joao A.C. Lima None ● Merck, Inc.
● Fujisawa Inc.
● Toshiba Inc.
● GEMS ● Toshiba Inc. None None
r. Warren J. Manning ● Amesham
Health
● Philips Medical
Systems
● Astra-Zeneca
● Bristol Myers
Imaging
None None None
r. Gerald M. Pohost ● White
Memorial
Hospital
● GE Healthcare None ● Takeda None None
r. Paolo M. Raggi None ● Pfizer None None None None
r. George P. Rodgers None None None None None None
r. John A. Rumberger None None None ● GE Healthcare None None
r. Allen J. Taylor None Kos None ● Pfizer
● Kos
● Wyeth
None None
his table represents the relationships of committee members with industry that were reported orally at the initial Writing Committee meeting and updated in conjunction with
ll meetings and conference calls of the Writing Committee during the document development process. It does not necessarily reflect relationships with industry at the time of
ublication.
